We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

40 hedge funds and large institutions have $5.83M invested in Microbot Medical in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

3% more funds holding

Funds holding: 39 → 40 (+1)

42% less capital invested

Capital invested by funds: $9.98M → $5.83M (-$4.15M)

Holders
40
Holders Change
+1
Holders Change %
+2.56%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
12
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.09M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$162K
3
VKH
Virtu KCG Holdings
New York
+$109K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$78.1K
5
BIT
BlackRock Institutional Trust
California
+$45.4K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.02M
2
SFM
Sphera Funds Management
Israel
-$612K
3
Goldman Sachs
Goldman Sachs
New York
-$101K
4
CS
Credit Suisse
Switzerland
-$20K
5
TRCT
Tower Research Capital (TRC)
New York
-$16.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
26
GSA Capital Partners
United Kingdom
$11K +$12.7K +7 New
Bank of America
27
Bank of America
North Carolina
$10K – – –
Citigroup
28
Citigroup
New York
$10K +$7.26K +4 +200%
BIA
29
Barry Investment Advisors
Massachusetts
$10K +$10.9K +6 New
GC
30
Guggenheim Capital
Illinois
$10K +$12.7K +7 New
LTFS
31
Ladenburg Thalmann Financial Services
Florida
$9K +$7.26K +4 +200%
UBS Group
32
UBS Group
Switzerland
$9K +$10.9K +6 New
SM
33
Sabby Management
Florida
$5.44K +$1.09M +598 +20%
TRCT
34
Tower Research Capital (TRC)
New York
$4K -$16.3K -9 -82%
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$3K – – –
RIA
36
Regal Investment Advisors
Michigan
$2K – – –
VIA
37
Vantage Investment Advisors
Pennsylvania
$2K – – –
Canada Life
38
Canada Life
Manitoba, Canada
$1K – – –
PNC Financial Services Group
39
PNC Financial Services Group
Pennsylvania
$1K – – –
TFA
40
Transamerica Financial Advisors
Florida
$1K – – –
Wells Fargo
41
Wells Fargo
California
$1K – – –
IF
42
IRON Financial
Illinois
$128 +$14.5K +8 New
AIG
43
American International Group
New York
$26 – – –
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
– -$2.02M -990 Closed
SFM
45
Sphera Funds Management
Israel
– -$612K -300 Closed
Goldman Sachs
46
Goldman Sachs
New York
– -$101K -49 Closed
CS
47
Credit Suisse
Switzerland
– -$20K -10 Closed
Fifth Third Bancorp
48
Fifth Third Bancorp
Ohio
– -$5K -2 Closed
1
2

MBOT Hedge Fund Activity: Q4 2014 in Review

40 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2014, worth a combined $5.83M — down 42% from $9.98M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new MBOT positions and 5 closed out — a net gain of 2 holders — while 12 added to existing stakes and 5 trimmed.

The largest buyer was Sabby Management, adding an estimated $1.09M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $2.02M sold.

  • 40 institutional investors held Microbot Medical (MBOT) as of Q4 2014, up from 39 in Q3 2014.
  • Funds reported $5.83M of Microbot Medical stock for Q4 2014, down 42% quarter-over-quarter.
  • 7 funds opened new Microbot Medical positions in Q4 2014 and 5 closed out, a net change of +2 holders.
  • The largest Microbot Medical buyer in Q4 2014 was Sabby Management, an estimated $1.09M added.
  • The largest Microbot Medical seller in Q4 2014 was Susquehanna International Group, an estimated $2.02M sold.

Based on aggregated 13F filings for Q4 2014.